Literatur
-
1
Ascherio A, Rimm E B, Hernan M A. et al .
Relation of consumption of vitamin E, vitamin
C, and carotenoids to risk for stroke among men in the United States.
Ann
Intern Med.
1999;
130
963-970
-
2
Blot W J, Li J Y, Taylor P R. et al .
Nutrition intervention trials in Linxian,
China: supplementation with specific vitamin/mineral combinations,
cancer incidence, and disease-specific mortality in the general
population.
J Natl Cancer Inst.
1993;
85
1483-1492
-
3
Bub A, Watzl B, Abrahamse S L.
Moderate
intervention with carotinoid-rich vegetable products reduce lipid
peroxidation in healthy volunteers.
J Nutr.
2000;
130
2200-2206
-
4
Castelluccio C, Bolwell G P, Gerrish C, Rice-Evans C A.
Differential
distribution of ferulic acid to the major plasma constituents in
relation to its potential as an antioxidant.
Biochem J.
1996;
316
691-694
-
5
Cook N C, Samman S.
Flavonoids - Chemistry,
metabolism, cardioprotective effects, and dietary sources.
J
Nutr Biochem.
1996;
7
66-76
-
6 DACH .Referenzwerte
für die Nährstoffzufuhr. 1. Auflage. Frankfurt,
Umschau Braus GmbH Verlagsgesellschaft 2000
-
7
Diaz M N, Frei B, Vita J A, Keaney J F.
Antioxidants
and atherosclerotic heart disease.
N Engl J Med.
1997;
337
408-416
-
8
Enstrom J E, Kanim L E, Klein M A.
Vitamin
C intake and mortality among a sample of the United States population.
Epidemiology.
1992;
3
194-202
-
9
Gale C R, Martyn C N, Winter P D, Cooper C.
Vitamin C and risk of death
from stroke and coronary heart disease in a cohort of elderly people.
Br
Med J.
1995;
310
1563-1566
-
10
Geleijnse J M, Launer L J, Hofman A, Pols H A, Witteman J C.
Tea
flavonoids may protect against atherosclerosis: the Rotterdam Study.
Arch
Intern Med.
1999;
159
2170-2174
-
11
GISSI-Prevenzione Investigators .
Dietary
supplementation with n-3 polyunsaturated fatty acids and vitamin
E after myocardial infarction: Results of the GISSI-Prevenzione
trial.
Lancet.
1999;
354
447-455
-
12
Graf E.
Antioxidant
potential of ferulic acid.
Free Radical Biol Med.
1992;
13
435-448
-
13
Heitzer T, Yla Herttuala S, Wild E, Luoma J, Drexler H.
Effect
of vitamin E on endothelial vasodilator function in patients with
hypercholesterolemia, chronic smoking or both.
J Am Coll
Cardiol.
1999;
33
499-505
-
14
Hertog M G, Sweetnam P M, Fehily A M. et al .
Antioxidant flavonols and ischaemic heart
disease in a Welsh population of men: The Caerphilly Study.
Am
J Clin Nutr.
1997;
65
1489-1494
-
15
Hertog M G, Feskens E JM, Hollman P CH. et al .
Dietary antioxidant flavonoids and risk
of coronary heart disease. The Zuphten Elderly Study.
Lancet.
1993;
342
1007-1011
-
16
Hodgson J M, Puddey I B, Croft K D, Mori T A, Rivera J, Beilin L J.
Isoflavonoids
do not inhibit in vivo lipid peroxidation in subjects with high-normal
blood pressure.
Atherosclerosis.
1999;
145
167-172
-
17
Joshipura K J, Ascherio A, Manson J E. et al .
Fruit and vegetable intake in relation
to risk of ischemic stroke.
JAMA.
1999;
282
1233-1239
-
18
Keli S O, Hertog M L, Feskens E JM. et al .
Dietary flavonoids, antioxidant vitamins,
and incidence of stroke.
Arch Intern Med.
1996;
156
637-642
-
19
Klipstein-Grobusch K, Launer L J, Geleijnse J M, Boeing H, Hofman A, Witteman J C.
Serum carotenoids
and atherosclerosis. The Rotterdam Study.
Atherosclerosis.
2000;
148
49-56
-
20
Klipstein-Grobush K, Geleijnse J M, den Breeijen J H. et al .
Dietary antioxidants and risk of myocardial
infarction in the elderly: The Rotterdam Study.
Am J Clin
Nutr.
1999;
69
261-266
-
21
Knekt P, Jarvinen R, Reunanen A. et al .
Flavonoid
intake and coronary mortality in Finland: a cohort study.
Br
Med J.
1996;
312
478-481
-
22
Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A.
Antioxidant
vitamin intake and coronary mortality in a longitudinal population
study.
Am J Epidemiol.
1994;
139
1180-1190
-
23
Kohlmeier L, Kark J D, Gomez-Gracia E. et al .
Lycopene and myocardial infarction risk
in the EURAMIC Study.
Am J Epidemiol.
1997;
146
618-626
-
24
Kushi L H, Folsom A R, Prineas R J, Mink P J, Ying W, Bostick R M.
Dietary antioxidant
vitamins and death from coronary heart disease in postemnopausal
women.
N Engl J Med.
1996;
334
1156-1162
-
25
Law M R, Morris J K.
By how much
does fruit and vegetable consumption reduce the risk of ischaemic
heart disease?.
Eur J Clin Nutr.
1998;
52
549-556
-
26
Lengfelder W.
Antioxidative
Vitamine: Prävention von kardiovaskulären Erkrankungen.
Dtsch
Med Wschr.
1998;
123
1014-1017
-
27
Martin K R, Wu D, Meydani M.
The
effect of carotenoids on the expression of cell surface adhesion
molecules and binding of monocytes to human aortic endothelial cells.
Atherosclerosis.
2000;
150
265-274
-
28
Miller N J, Sampson J, Candeias L P, Bramley P M, Rice-Evans C A.
Antioxidant
activities of carotenes and xanthophylls.
FEBS Lett.
1996;
384
240-242
-
29
Morris D L, Krichevsky S B, Davis C E.
Serum
carotenoids and coronary heart disease. The Lipid Research Clinics
Coronary Primary Prevention Trial and Follow-up.
JAMA.
1994;
272
1439-1441
-
30
Morton L W, Abu-Amsha C R, Puddey I B, Croft K D.
Chemistry and biological
effects of dietary phenolic compounds: Relevance to cardiovascular
disease.
Clin Exp Pharmacol Physiol.
2000;
27
152-159
-
31
Nardini M, Natella F, Gentili V, DiFelice M, Scaccini C.
Effect
of caffeic acid dietary supplementation on the antioxidant defense
system in rat: An in vivo study.
Arch Biochem Biophys.
1997;
342
157-160
-
32
Omenn G S, Goodman G E, Thornquist M D. et al. .
Effects of a combination of
beta-carotene and vitamin A on lung cancer and cardiovascular disease.
N Engl J Med.
1996;
334
1150-1155
-
33
Paolisso G, Esposito R, D’Alessio M
A, Barbieri M.
Primary and secondary prevention of atherosclerosis:
is there a role for antioxidants?.
Diabetes Metab.
1999;
298
306
-
34
Rapola J M, Virtamo J, Ripatti S. et al .
Randomised trial of (α-tocopherol
and β-carotene supplements on incidence of major coronary
events in men with previous myocardial infarction.
Lancet.
1997;
349
1715-1720
-
35
Rice-Evans C A, Miller N J, Paganga G.
Structure-antioxidant
activity relationships of flavonoids and phenolic acids.
Free
Radical Biol Med.
1996;
20
933-956
-
36
Rimm E, Katan M B, Ascherio A. et al .
Relation
between intake of flavonoids and risk for coronary heart disease
in male health professionals.
Ann Intern Med.
1996;
125
384-389
-
37
Rimm E B, Stampfer M J, Ascherio A, Giovannucci E, Colditz G A, Willett W C.
Vitamin E
consumption and the risk of coronary heart disease in men.
N
Engl J Med.
1993;
328
1450-1456
-
38
Samman S, Lyons W all PM, Chan G S, Smith S J, Petocz P.
The
effect of supplementation with isoflavons on plasma lipids and oxidisability
of low density lipoprotein in premenopausal women.
Atherosclerosis.
1999;
147
277-283
-
39
Solzbach U, Horning B, Jeserich M, Just H.
Vitamin C improves endothelial
dysfunction of epicardial coronary arteries in hypertensive patients.
Circulation.
1997;
96
1513-1519
-
40
Stampfer M J, Hennekens C H, Manson J E, Colditz G A, Rosner B, Willett W C.
Vitamin E
consumption and the risk of coronary disease in women.
N
Engl J Med.
1993;
328
1444-1449
-
41
Stephens N G, Parsons A, Schofield P M. et al .
Randomised controlled trial of vitamin
E in patients with coronary disease: Cambridge Heart Antioxidant
Study (CHAOS).
Lancet.
1996;
347
781-786
-
42
Tardif J -C, Cote G, Lesperance J. et al. Multivitamins and Probucol Study Group .
Probucol
and multivitamins in the prevention of restenosis after coronary
angioplasty.
N Engl J Med.
1997;
337
365-372
-
43
The Heart Outcomes Prevention
Evaluation Study Investigators .
Vitamin E supplementation
and cardiovascular events in high-risk patients.
N Engl
J Med.
2000;
342
154-160
-
44
Tikkanen M J, Wähälä K, Ojala S, Vihma V, Adlercreutz H.
Effect
of soybean phytoestrogen intake on low density lipoprotein oxidation
resistance.
Proc Natl Acad Sci USA.
1998;
95
3106-3110
-
45
Ting H H, Timini F K, Haley E A, Roddy M A, Ganz P, Creager M A.
Vitamin C
improves endothelium-dependent vasodilation in forearm resistance
vessels of humans with hypercholesterolemia.
Circulation.
1997;
95
2617-2622
-
46
Todd S, Woodward M, Tunstall-Pedoe H, Bolton-Smith C.
Dietary antioxidant
vitamins and fiber in the etiology of cardiovascular disease and
all-causes mortality: results from the Scottish Heart Health Study.
Am
J Epidemiol.
1999;
150
1073-1080
-
47
Vanharanta M, Voutilainen S, Lakka T A, van der Lee M, Adlercreutz H, Salonen J T.
Risk of acute
coronary events according to serum concentrations of enterolactone:
a prospective population-based case-control study.
Lancet.
1999;
354
2112-2115
-
48 Watzl B, Leitzmann C. Bioaktive Substanzen
in Lebensmitteln. 2. Auflage. Stuttgart, Hippokrates
Verlag 1999
-
49
Wiseman H, O’Reilly J D, Adlercreutz H. et al .
Isoflavons phytoestrogens consumed in soy
decrease F2-isoprostane concentrations and increase resistance of
low-density lipoproteins to oxidation in humans.
Am J
clin Nutr.
2000;
72
395-400
-
50
Yochum L, Kushi L H, Meyer K, Folsom A R.
Dietary flavonoid
intake and risk of cardiovascular disease in postmenopausal women.
Am J
Epidemiol.
1999;
149
943-949
Korrespondenz
Prof. Dr. Hans Hauner
Deutsches Diabetes-Forschungsinstitut an der
Heinrich-Heine-Universität
Auf’m Hennekamp 65
40225 Düsseldorf
Phone: 0211/33821
Fax: 0211/3382-339
Email: hauner@dfi.uni-duesseldorf.de
